TWIST BIOSCIENCE

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	3	1
2019	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ERIN SMITH/ SMITH CAPITOL STRATEGIES	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	4
SENATE	4
Food & Drug Administration (FDA)	2
Natl Institutes of Health (NIH)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Science/Technology	Science/Technology	5
Health Issues	Health Issues	1
Budget/Appropriations	Budget/Appropriations	1

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2740116th Congress

Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020

2020 · second_quarter · Firm: ERIN SMITH/ SMITH CAPITOL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number

Client expense: — · Firm income: —

Matched citations: H.R.2740

H.R. 4373116th Congress

Engineering Biology Research and Development Act of 2019

2020 · second_quarter · Firm: ERIN SMITH/ SMITH CAPITOL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Supporting the bioeconomy COVID-19 synthetic biology policy H.R.4373 - Engineering Biology Research and Development Act of 2019 S. 3734 Bioeconomy Development Act of 2020 Biosecurity standards American competitiveness

Client expense: — · Firm income: —

Matched citations: H.R.4373

S. 3734116th Congress

Bioeconomy Research and Development Act of 2020

2020 · second_quarter · Firm: ERIN SMITH/ SMITH CAPITOL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Supporting the bioeconomy COVID-19 synthetic biology policy H.R.4373 - Engineering Biology Research and Development Act of 2019 S. 3734 Bioeconomy Development Act of 2020 Biosecurity standards American competitiveness

Client expense: — · Firm income: —

Matched citations: S. 3734

H.R. 4373116th Congress

Engineering Biology Research and Development Act of 2019

2019 · fourth_quarter · Firm: ERIN SMITH/ SMITH CAPITOL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts